Literature DB >> 21712255

Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases.

Hua Meng1, Xin Wang, Yuman Fong, Zi-Han Wang, Yu Wang, Zhong-Tao Zhang.   

Abstract

OBJECTIVE: The objective of this study was to investigate whether radical surgical treatment can be associated with reasonable survival for patients with Stage IV gallbladder cancer with distant lymph node metastasis.
METHODS: Fifty-five patients (20 men and 35 women) with complete clinical and follow-up data for Japanese Society of Biliary Surgery TNM system Stage IV gallbladder cancer were included in our study. Patients were divided into three treatment groups for clinical analysis: Group A (radical resection, n = 24), Group B (chemotherapy, n = 8) and Group C (other palliative treatment, n = 23).
RESULTS: The survival rate in Group A was significantly higher when compared with Groups B (P=0.008) and C (P=0.004). Moreover, the prognosis of patients with distant lymph node metastasis (Group A2, Japanese Society of Biliary Surgery N3; American Joint Committee on Cancer M1) was significantly worse versus those with local lymph node metastasis (Group A1, Japanese Society of Biliary Surgery N1-N2; American Joint Committee on Cancer N1) (P=0.007). Most importantly, no significant difference in the survival rate was observed between patients in Group A2 and Groups B (P = 0.47) or C (P = 0.74).
CONCLUSIONS: Radical resection might result in a reasonable prognosis for gallbladder cancer patients with local metastasis of the lymph nodes (Japanese Society of Biliary Surgery N1-N2), but was not effective when distant lymph nodes (Japanese Society of Biliary Surgery N3) were involved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21712255     DOI: 10.1093/jjco/hyr072

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  12 in total

1.  Gallbladder cancer: expert consensus statement.

Authors:  Thomas A Aloia; Nicolas Járufe; Milind Javle; Shishir K Maithel; Juan C Roa; Volkan Adsay; Felipe J F Coimbra; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

2.  Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre.

Authors:  Santosh Kumar Singh; Rajnish Talwar; Narayanan Kannan; Arvind Kumar Tyagi; Pradeep Jaiswal; Adarsh Kumar
Journal:  J Gastrointest Cancer       Date:  2018-09

3.  Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.

Authors:  Xiao-Dong He; Jing-Jing Li; Wei Liu; Qiang Qu; Tao Hong; Xie-Qun Xu; Bing-Lu Li; Ying Wang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

4.  Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.

Authors:  Kaitlyn J Kelly; Katerina Dukleska; Deborah Kuk; T Peter Kingham; Michael I D'Angelica; Ronald P DeMatteo; Peter J Allen; William R Jarnagin; Yuman Fong
Journal:  Ann Surg Oncol       Date:  2013-11-09       Impact factor: 5.344

5.  Impact of pre-operative positron emission tomography in gallbladder cancer.

Authors:  Universe Leung; Neeta Pandit-Taskar; Carlos U Corvera; Michael I D'Angelica; Peter J Allen; T Peter Kingham; Ronald P DeMatteo; William R Jarnagin; Yuman Fong
Journal:  HPB (Oxford)       Date:  2014-06-04       Impact factor: 3.647

6.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

7.  Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer.

Authors:  Jae Pil Hwang; Ilhan Lim; Im Ii Na; Eung Ho Cho; Byung Ii Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

8.  Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

Authors:  Natasha Leigh; Daniel Solomon; Eric Pletcher; Daniel M Labow; Deepa R Magge; Umut Sarpel; Benjamin J Golas
Journal:  World J Surg Oncol       Date:  2020-06-11       Impact factor: 2.754

9.  Laparoscopic radical cholecystectomy with common bile duct resection for T2 gallbladder cancer.

Authors:  Jonathan Geograpo Navarro; Chang Moo Kang
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-02-28

10.  Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer.

Authors:  Chen Chen; Lin Wang; Rui Zhang; Qi Li; Ya-Ling Zhao; Guan-Jun Zhang; Wen-Zhi Li; Zhi-Min Geng
Journal:  Chronic Dis Transl Med       Date:  2019-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.